Category: Finance
-
Venture Philanthropy Funds Rare Neuro Disease Trial
A gene therapy start-up is receiving an award resembling venture financing to advance its treatment for a rare inherited neuromuscular disorder to clinical trials.
-
New Biotech Aims to Bring Down Drug Prices
A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs.
-
Light-Activated Brain Electrodes in Development
A wireless electrode activated by light waves is being developed to connect with nerve cells in the brain that promises to make brain-computer connections safer.
-
Vaccine Developer Gains $11M in Early Funds
A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round.
-
Infographic – Biotech Index Zooms to New High
Since October, the Nasdaq Biotechnology Index rose steadily to a new high for the year, as shown in this weekend’s infographic.
-
Synthetic Bio Cancer Immunotherapy Company Acquired
A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma.
-
Commentary – New Models Needed for Antibiotic Resistance
Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge.
-
Climate Action Cost Accounting Standard Proposed
A new paper proposes an accounting standard that would require private companies to spell out their costs of meeting net-zero greenhouse gas emissions.
-
Touch Sensor Developer Gains $12M in Early Funds
A company making gloves that transmit a sense of touch in games and commercial robotics is raising $12 million in its first venture funding round.
-
Duke Univ Forms Drug Development Company
Duke University and life science investor Deerfield Management are forming a new enterprise to develop drug candidates through early development stages.